DOVER, Del., Nov. 6, 2025 /PRNewswire/ -- Mwyngil Therapeutics Inc., a biopharmaceutical company dedicated to developing first-in-class and best-in-class small-molecule therapies...
Held meeting with U.S. Food and Drug Administration (FDA) where, among other things, they reiterated October 2024 agreement to use...
Society for Neuroscience Annual Meeting, November 15-19, San Diego, CAWALTHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sironax, a global...
The ballot measure was supported by national and local neurodegenerative disease organizations, including The Michael J. Fox Foundation (MJFF). MJFF...
JENKINTOWN, PA / ACCESS Newswire / November 5, 2025 / SarahCare Adult Day Center of Jenkintown is thrilled to announce...
This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin’s frequency neurostimulator as a...
WESTBROOK, Maine, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company,...
New NIH grant awards $2.5 million over 5 years for mechanistic studyBURLINGTON, Mass. and JERUSALEM, Nov. 04, 2025 (GLOBE NEWSWIRE)...
ATLAS GPT Brings Award-Winning Surgical Excellence to Transform Clinical Decision-Making Across All Healthcare Disciplines LOS ANGELES, Nov. 4, 2025 /PRNewswire/...
The New Formula Joins the $11.8 Billion Global Sleep and Recovery Supplement Market as Part of theBrand's Growing Collection of...
DARIEN, Conn., Nov. 3, 2025 /PRNewswire/ -- Medical device maker CEFALY Technology announced today that CEFALY Connected has become the...
Deals leveraged $86.9 million in outside capital in the first quarter of the fiscal year NEW HAVEN, Conn., Nov. 3,...
BOWIE, Md., Nov. 3, 2025 /PRNewswire/ -- The Epilepsy Foundation of America (EFA) is calling on people across the country...
November 3, 2025 Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient...
120-Day Safety Update Submitted to FDA ORCA-OL Long-Term Safety Trial Successfully ConcludedDSMC Completes Final Review of Cytisinicline, Finds No Drug...
Augmented Reality Glasses Purpose-Built for the Medical Technology IndustryMUNICH & HYATTSVILLE, Md.--(BUSINESS WIRE)--#AIHealthcare--MDIC Medical XR Summit – Snke OS GmbH...
American Heart Association consortium advances development of evidence-based health tech solutions CHICAGO and OXFORD, England, Oct. 31, 2025 /PRNewswire/ --...
Unprecedented global turnout defined 2025 edition as 6,800 tech enterprises, 2,000 startups, 1,200 investors, and tech representatives from 180 nations...
Upgraded design + synthesis engine targets broad mutant coverage with wild‑type EGFR sparing; active collaboration advances toward scale‑up and CMC...
HOUSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...